Literature DB >> 12165200

Immunoglobulin G subclass deficiency: fact or fancy?

Rebecca H Buckley1.   

Abstract

Over the past four decades, many patients have been reported to have deficiencies of one or more subclasses of immunoglobulin G (IgG), despite normal total IgG serum concentrations. However, except for those with extremely low or absent IgG2 concentrations and an inability to produce antibodies to polysaccharide antigens, it is difficult to know the true biologic significance of the many reported IgG subclass deficiencies. Completely asymptomatic individuals who totally lack IgG1, IgG2, IgG4, or IgA1 because of heavy-chain gene deletions have been described as producing antibodies normally. In addition, numerous healthy children who have low levels of IgG2 but normal responses to polysaccharide antigens when immunized have been similarly described. From these observations, it can be concluded that IgG subclass measurement is not very helpful in the general assessment of immune function. Such assays provide no information about the patient's capacity to produce specific antibodies to protein, polysaccharide, or viral antigens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165200     DOI: 10.1007/s11882-002-0067-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  49 in total

Review 1.  IgG subclass deficiency and the day-care generation.

Authors:  A R Lawton
Journal:  Pediatr Infect Dis J       Date:  1999-05       Impact factor: 2.129

2.  Relationship between IgA and IgG subclass deficiencies: a reappraisal.

Authors:  A Plebani; V Monafo; M A Avanzini; A G Ugazio; G R Burgio
Journal:  Monogr Allergy       Date:  1986

3.  An immunodeficiency characterized by impaired antibody responses to polysaccharides.

Authors:  D M Ambrosino; G R Siber; B A Chilmonczyk; J B Jernberg; R W Finberg
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

4.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

Authors:  R Jefferis; C B Reimer; F Skvaril; G de Lange; N R Ling; J Lowe; M R Walker; D J Phillips; C H Aloisio; T W Wells
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

5.  Immunoglobulin subclasses in normal children.

Authors:  P H Schur; F Rosen; M E Norman
Journal:  Pediatr Res       Date:  1979-03       Impact factor: 3.756

6.  Impaired IgG responses in a child with homozygous C2 deficiency and recurrent pneumococcal septicaemia.

Authors:  J T Attwood; Y Williams; C Feighery
Journal:  Acta Paediatr       Date:  2001-01       Impact factor: 2.299

7.  Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels.

Authors:  M Armenaka; J Grizzanti; D L Rosenstreich
Journal:  Ann Allergy       Date:  1994-06

8.  Metabolic properties of IgG subclasses in man.

Authors:  A Morell; W D Terry; T A Waldmann
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

9.  IgG subclasses: development of the serum concentrations in "normal" infants and children.

Authors:  A Morell; F Skvaril; W H Hitzig; S Barandun
Journal:  J Pediatr       Date:  1972-06       Impact factor: 4.406

10.  Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels.

Authors:  D M Ambrosino; D T Umetsu; G R Siber; G Howie; T A Goularte; R Michaels; P Martin; P H Schur; J Noyes; G Schiffman
Journal:  J Allergy Clin Immunol       Date:  1988-06       Impact factor: 10.793

View more
  23 in total

1.  Assessment and clinical interpretation of reduced IgG values.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2007-09       Impact factor: 6.347

2.  Immunoglobulins and complement factor C4 in adult rhinosinusitis.

Authors:  M Seppänen; J Suvilehto; M-L Lokki; I-L Notkola; A Järvinen; H Jarva; I Seppälä; O Tahkokallio; H Malmberg; S Meri; V Valtonen
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Similar but not consistent: Revisiting the pitfalls of measuring IgG subclasses with different assays.

Authors:  Beatrice Ludwig-Kraus; Frank Bernhard Kraus
Journal:  J Clin Lab Anal       Date:  2017-01-16       Impact factor: 2.352

4.  Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy.

Authors:  F Abrahamian; S Agrawal; S Gupta
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

Review 5.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

6.  [Adult-onset primary immunodeficiencies].

Authors:  S Gadola; U Salzer; H Schultz; B Grimbacher
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

Review 7.  The genetics of hypogammaglobulinemia.

Authors:  Bodo Grimbacher; Alejandro A Schäffer; Hans-Hartmut Peter
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 8.  Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness.

Authors:  Christopher J Ocampo; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2013-01       Impact factor: 2.467

Review 9.  Immunoglobulin replacement therapy in children.

Authors:  Maria Garcia-Lloret; Sean McGhee; Talal A Chatila
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479

10.  Primary immunodeficiency diseases in Australia and New Zealand.

Authors:  Philippa Kirkpatrick; Sean Riminton
Journal:  J Clin Immunol       Date:  2007-06-22       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.